Comparing Beauty Health (NASDAQ:SKIN) and Getinge (OTCMKTS:GNGBY)

Getinge (OTCMKTS:GNGBY) and Beauty Health (NASDAQ:SKIN) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, profitability and analyst recommendations.

Profitability

This table compares Getinge and Beauty Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Getinge	6.54%	10.60%	5.47%
Beauty Health	-3.16%	-15.40%	-1.74%

Analyst Ratings

This is a breakdown of current recommendations and price targets for Getinge and Beauty Health, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Getinge	0	1	1	0	2.50
Beauty Health	1	6	1	0	2.00

Beauty Health has a consensus target price of $2.42, suggesting a potential upside of 191.92%. Given Beauty Health’s higher probable upside, analysts clearly believe Beauty Health is more favorable than Getinge.

Institutional and Insider Ownership

93.3% of Beauty Health shares are held by institutional investors. 41.0% of Beauty Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Risk and Volatility

Getinge has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500. Comparatively, Beauty Health has a beta of 1.24, suggesting that its stock price is 24% more volatile than the S&P 500.

Earnings & Valuation

This table compares Getinge and Beauty Health”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Getinge	$3.57 billion	1.56	$230.87 million	$0.86	23.77
Beauty Health	$300.80 million	0.35	-$9.52 million	($0.20)	-4.15

Getinge has higher revenue and earnings than Beauty Health. Beauty Health is trading at a lower price-to-earnings ratio than Getinge, indicating that it is currently the more affordable of the two stocks.

Summary

Getinge beats Beauty Health on 9 of the 13 factors compared between the two stocks.

About Getinge

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions. In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

About Beauty Health

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.